Literature DB >> 30997238

Is it worth to apply extra-corporeal membrane oxygenation in the immunocompromised patients with severe acute respiratory distress syndrome?

Carmen Silvia Valente Barbas1,2, Gustavo Faissol Janot de Matos2,3.   

Abstract

Entities:  

Year:  2019        PMID： 30997238      PMCID： PMC6424749          DOI： 10.21037/jtd.2018.11.46

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.

Authors:  Alain Combes; David Hajage; Gilles Capellier; Alexandre Demoule; Sylvain Lavoué; Christophe Guervilly; Daniel Da Silva; Lara Zafrani; Patrice Tirot; Benoit Veber; Eric Maury; Bruno Levy; Yves Cohen; Christian Richard; Pierre Kalfon; Lila Bouadma; Hossein Mehdaoui; Gaëtan Beduneau; Guillaume Lebreton; Laurent Brochard; Niall D Ferguson; Eddy Fan; Arthur S Slutsky; Daniel Brodie; Alain Mercat
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

2.  Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study.

Authors:  Matthieu Schmidt; Peter Schellongowski; Nicolò Patroniti; Fabio Silvio Taccone; Dinis Reis Miranda; Jean Reuter; Helène Prodanovic; Marc Pierrot; Amandine Dorget; Sunghoon Park; Martin Balik; Alexandre Demoule; Ilaria Alice Crippa; Alain Mercat; Philipp Wohlfarth; Romain Sonneville; Alain Combes
Journal:  Am J Respir Crit Care Med       Date:  2018-05-15       Impact factor: 21.405

3.  A Comparative Analysis of Survival Prediction Using PRESERVE and RESP Scores.

Authors:  Hye-Rin Kang; Dong Jung Kim; Jinwoo Lee; Young-Jae Cho; Jun Sung Kim; Sang-Min Lee; Jae-Ho Lee; Sanghoon Jheon; Choon-Taek Lee; Yeon Joo Lee
Journal:  Ann Thorac Surg       Date:  2017-04-12       Impact factor: 4.330

4.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

5.  Acute respiratory distress syndrome in patients with malignancies.

Authors:  Elie Azoulay; Virginie Lemiale; Djamel Mokart; Frédéric Pène; Achille Kouatchet; Pierre Perez; François Vincent; Julien Mayaux; Dominique Benoit; Fabrice Bruneel; Anne-Pascale Meert; Martine Nyunga; Antoine Rabbat; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-06-05       Impact factor: 17.440

6.  Use of ECMO in ARDS: does the EOLIA trial really help?

Authors:  Luciano Gattinoni; Francesco Vasques; Michael Quintel
Journal:  Crit Care       Date:  2018-07-05       Impact factor: 9.097
  6 in total
  1 in total

1.  Extra Corporeal Membrane Oxygenation in the Treatment of Human Immunodeficiency Virus-Related P. jirovecii Pneumonia.

Authors:  Sara Lacerda Pereira; Elsa Branco; Ana Sofia Faustino; Paulo Figueiredo; António Sarmento; Lurdes Santos
Journal:  Infect Dis Rep       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.